Skip to main content

somaHRD, a versatile, cost efficient and clinically validated HRD solution

SeqOne’s somaHRD offers:

  • Machine learning clinically validated solution against reference PAOLA-1 cohort

  • Seamless lab workflow integration with sWGS & BRCA Panel results into a single report and Agilent Magnis single flowcell (panel + sWGS)

  • Compatibility with all wetlabs

  • Transparent reporting, including QC metrics, actionable information

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer,
European Journal of Cancer, 2024

Download product brochure

Transparent reporting, actionable information

  • One line HRD status summary

  • % cellularity (provided by the pathologist)

  • Confidence interval of the HRD probability

  • Low tumor profile status detected by sWGS analysis

  • HRD probability score features:
    • LGA (Large genomic Alteration Status)
    • LPC (Loss of Parental Copy Status)

  • BRCA/TP53  pathogenic SNV/indels and VAF details

  • Copy number variation at CCNE1 provided and profiles per chromosome

SeqOne Genomic analysis platform

Secure. Scalable. Proven.

  • Used in Routine by 1000+ users in multiple very high-volume labs 

  • Free trial testing, transparent usage-based pricing (‘fee per analysis’)

  • Unlimited user accounts and secured cloud health data storage at no additional costs.

  • International Customer Support and Application Specialists.

  • Automated data workflow from Sequencer (upload, analysis, exports) with SeqOne Data Sync

  • Compliant with data privacy and requirements with ISO/IEC 27001:2013 certifications and guaranteed data residency